Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BioSpecifics Technologies Corp. Company Profile (NASDAQ:BSTC)

Consensus Ratings for BioSpecifics Technologies Corp. (NASDAQ:BSTC) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $46.00 (18.16% upside)

Analysts' Ratings History for BioSpecifics Technologies Corp. (NASDAQ:BSTC)
Show:
DateFirmActionRatingPrice TargetActions
12/23/2014AegisReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2014MKM PartnersBoost Price TargetBuy$38.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014MKM PartnersBoost Price TargetBuy$28.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2014MKM PartnersBoost Price TargetBuy$24.50 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2013MKM PartnersBoost Price TargetBuy$23.50 -> $24.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2013MKM PartnersBoost Price TargetBuy$21.00 -> $23.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013JMP SecuritiesInitiated CoverageOutperform$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/22/2013 forward)